425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. announced a proposed business combination, with Strive's CEO reposting the communication on X.com.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication was reposted by Matthew Cole, Chief Executive Officer of Strive, Inc., on X.com on September 25, 2025.
• The transaction involves Strive issuing additional shares of its Class A common stock.
• Strive intends to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, to register the shares and seek Semler Scientific stockholder approval.
• Investors are cautioned regarding numerous forward-looking statements and associated risks related to the proposed transaction.

Sentiment

Score: 6

Explanation: The filing announces a significant corporate action (merger) which is generally positive for strategic growth, but it is heavily weighted with extensive cautionary statements and risks, leading to a neutral-to-slightly-positive sentiment rather than strongly positive.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are a potential outcome of the business combination.

Risks

• The merger agreement could be terminated due to unforeseen events, changes, or circumstances.
• The proposed transaction may not close as expected or at all if closing conditions are not met timely.
• Potential legal proceedings against Strive, Semler Scientific, or the combined company could impact the transaction.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Changes in or problems arising from Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets could affect outcomes.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory enforcement pose risks.
• Integration of the two companies could be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unforeseen factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional Class A common stock in connection with the transaction will cause dilution.
• Potential adverse reactions from customers or changes to business or employee relationships could result from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing could occur.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed business combination, including potential cost savings and strategic gains. The transaction's success hinges on meeting closing conditions, successful integration, and navigating various market and regulatory risks, including those related to Bitcoin treasury strategies.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., reposted the communication on X.com on September 25, 2025, in connection with the proposed business combination.

Industry Context

The filing highlights the increasing relevance of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' in corporate financial planning, indicating a trend where companies are exploring or adopting digital asset holdings as part of their treasury management.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a risk factor for the proposed transaction.

Related Party Transactions

• Information regarding Semler Scientific's transactions with related persons is set forth in its definitive proxy statement for its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders of Strive will experience dilution due to the issuance of additional Class A common stock in connection with the proposed transaction.
• Customers and employees of both Strive and Semler Scientific may have adverse reactions or changes to their relationships due to the announcement or completion of the transaction.
• Semler Scientific stockholders will be asked to approve the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will vote to approve the proposed transaction.
• Strive and Semler Scientific will continue to file other relevant documents with the SEC concerning the proposed transaction.

Key Dates

Keywords

Strive Inc, Semler Scientific Inc, Merger, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Digital Assets, Corporate Governance, Investment